Chuanwang Miao

455 total citations
12 papers, 77 citations indexed

About

Chuanwang Miao is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Chuanwang Miao has authored 12 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Chuanwang Miao's work include Esophageal Cancer Research and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Chuanwang Miao is often cited by papers focused on Esophageal Cancer Research and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). Chuanwang Miao collaborates with scholars based in China, United States and United Kingdom. Chuanwang Miao's co-authors include Shuanghu Yuan, Jinming Yu, Xudong Hu, Wanhu Li, Zhen Chen, Shan Zhu, Xiaoyue Wang, Xiangjie Niu, Lin Ai and Yachen Liu and has published in prestigious journals such as Frontiers in Immunology, Signal Transduction and Targeted Therapy and Oncotarget.

In The Last Decade

Chuanwang Miao

9 papers receiving 77 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanwang Miao China 5 40 36 26 25 14 12 77
Wei-Han Hu China 4 46 1.1× 49 1.4× 53 2.0× 14 0.6× 15 1.1× 6 118
Eric Lander United States 4 32 0.8× 36 1.0× 24 0.9× 11 0.4× 18 1.3× 9 71
Natalia Fadeeva Russia 5 53 1.3× 23 0.6× 46 1.8× 12 0.5× 11 0.8× 13 83
Philip J.S. Charlesworth United Kingdom 4 40 1.0× 22 0.6× 18 0.7× 49 2.0× 39 2.8× 7 102
Chloé Leandri France 5 38 0.9× 53 1.5× 34 1.3× 19 0.8× 16 1.1× 15 117
Xuping Xi China 5 37 0.9× 16 0.4× 30 1.2× 26 1.0× 13 0.9× 9 96
O. Fernández-Calvo Spain 5 33 0.8× 33 0.9× 56 2.2× 23 0.9× 5 0.4× 11 98
Adam Pennycuick United Kingdom 5 27 0.7× 33 0.9× 14 0.5× 18 0.7× 19 1.4× 10 79
Michaela K. Keck United States 6 43 1.1× 18 0.5× 54 2.1× 32 1.3× 22 1.6× 13 106

Countries citing papers authored by Chuanwang Miao

Since Specialization
Citations

This map shows the geographic impact of Chuanwang Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanwang Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanwang Miao more than expected).

Fields of papers citing papers by Chuanwang Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanwang Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanwang Miao. The network helps show where Chuanwang Miao may publish in the future.

Co-authorship network of co-authors of Chuanwang Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanwang Miao. A scholar is included among the top collaborators of Chuanwang Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanwang Miao. Chuanwang Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Li, Wenyu, et al.. (2025). Research progress on the impact of opioids on the tumor immune microenvironment (Review). Molecular and Clinical Oncology. 22(6). 1–11.
5.
Zhang, Xiqin, et al.. (2023). The prognostic value of 11th Japanese classification and 8th AJCC staging systems in Chinese patients with esophageal squamous cell carcinoma. Journal of Cardiothoracic Surgery. 18(1). 251–251. 1 indexed citations
6.
Liu, Yachen, Meng Wu, Xiangjie Niu, et al.. (2023). PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy. Cell & Bioscience. 13(1). 67–67. 7 indexed citations
8.
Liu, Weiling, Chuanwang Miao, Shaosen Zhang, et al.. (2021). VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduction and Targeted Therapy. 6(1). 322–322. 26 indexed citations
9.
Miao, Chuanwang, Wei Zhao, Shuanghu Yuan, et al.. (2017). A novel molecular agent for glioma angiogenesis imaging. Nuclear Medicine Communications. 38(11). 919–926. 3 indexed citations
10.
Wang, Xiaoyue, Chuanwang Miao, Zhen Chen, et al.. (2017). Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis. OncoTargets and Therapy. Volume 10. 2087–2095. 21 indexed citations
11.
Miao, Chuanwang, Shan Zhu, Hong Pan, et al.. (2017). Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy. Oncotarget. 8(50). 87971–87979. 7 indexed citations
12.
Zhu, Shan, Chuanwang Miao, Zhongtang Wang, Peng Li, & Baosheng Li. (2016). Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma. OncoTargets and Therapy. Volume 9. 6187–6193. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026